Y.Enterocolitica (O:9) YopE

Yersinia Enterocolitica (O:9) YopE Recombinant
Shipped with Ice Packs
In Stock

Description

Role in Immune Evasion and Pathogenesis

YopE contributes to bacterial survival through:

  • Phagocytosis Resistance: Inhibits actin polymerization in macrophages and polymorphonuclear leukocytes (PMNs) .

    • Synergizes with YopH, YopT, and YopO to block both opsonic and non-opsonic phagocytosis .

    • Notably, YopE’s role in opsonic phagocytosis is less pronounced in J774 macrophages compared to PMNs .

  • Cytotoxic Effects: Accumulation of stable YopE in O:9 strains enhances host cell cytotoxicity .

Serogroup-Specific Adaptations

Table 2: YopE Stability Across Y. enterocolitica Serogroups

SerogroupLysine Residues (Positions 62/75)UbiquitinationProteasomal DegradationCytotoxicity
O:8Present (K62/K75)YesYesModerate
O:9AbsentNoNoHigh
  • O:9-Specific Stability: The absence of K62/K75 in O:9 YopE prevents polyubiquitination, allowing prolonged intracellular activity .

  • Pathogenic Consequences: Stabilized YopE in O:9 correlates with reduced bacterial dissemination in murine models, suggesting a regulatory role in balancing effector delivery .

Comparative Pathogenicity Insights

  • YopE vs. Other Yops: While YopH and YopT broadly inhibit phagocytosis, YopE’s impact is context-dependent:

    • Critical for countering non-opsonic phagocytosis but less essential in opsonic contexts .

    • Hyperaccumulation of YopE in O:9 strains reduces translocation of other effectors (e.g., YopP, YopH), fine-tuning immune modulation .

  • Animal Models: O:9 YopE contributes to systemic infection but is less critical than YopH or YopP for lethality .

Research Implications and Applications

  • Therapeutic Targets: YopE’s GAP domain is a potential candidate for inhibitors to restore phagocytic function .

  • Diagnostic Use: Recombinant YopE (e.g., Surmodics A43700) is utilized in serological assays to detect Yersinia infections .

Product Specs

Introduction
Yersinia enterocolitica, a pathogenic bacterium, utilizes a plasmid-encoded type 3 secretion system to inject Yersinia outer proteins (Yops) into host cells. Among these Yops, YopE functions as a GTPase activation protein that disrupts the host cell's actin cytoskeleton. It achieves this by activating small Rho GTPases, leading to the inhibition of actin polymerization and ultimately affecting cellular processes.
Description
Recombinant Yersinia enterocolitica (O:9) YopE, produced in E.coli, is a non-glycosylated polypeptide chain with a calculated molecular mass of 24kDa. This protein is expressed with a -10x His tag at its N-terminus to facilitate purification, which is carried out using proprietary chromatographic techniques.
Physical Appearance
The product is a clear solution that has been sterilized through filtration.
Formulation
Y.Enterocolitica (O:9) YopE is provided in a buffer solution containing 20mM HEPES (pH 7.6), 250mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be kept at 4°C. For longer periods, it should be stored frozen at -20°C. To maintain product integrity, avoid repeated freeze-thaw cycles.
Purity
The purity of the recombinant Y.Enterocolitica (O:9) YopE is determined by SDS-PAGE analysis and is confirmed to be greater than 80%.
Synonyms

Outer membrane virulence protein YopE, yopE, yop25.

Source

Escherichia Coli.

Immunological Activity
Binds IgG- and IgM-type human antibodies.

Q&A

What is YopE and what is its role in Y. enterocolitica virulence?

YopE is a virulence plasmid-encoded cytotoxin produced by pathogenic Yersinia enterocolitica. It is translocated into target cells where it disrupts the actin cytoskeleton, contributing significantly to bacterial pathogenesis. YopE functions as a critical virulence factor by preventing phagocytosis of the bacteria by macrophages, neutrophils, and epithelial cells, thereby enabling bacterial survival in host tissues .

Research has demonstrated that YopE specifically targets the small GTPase RhoA, leading to its modification and cellular redistribution. This interaction results in the disruption of RhoA-controlled actin stress fibers, which is central to YopE's cytotoxic activity .

How is YopE translocated into host cells?

YopE is delivered into host cells through the type III secretion system (T3SS), a specialized molecular machine that spans the bacterial cell envelope. The translocation process requires several functional components, including:

  • YscN: An ATPase that provides energy for the secretion process

  • YopB/YopD: Proteins that form a translocation pore in the host cell membrane

  • SycE: A specific chaperone required for efficient YopE secretion

Experimental tracking systems using YopE-beta-lactamase hybrid proteins have revealed that beta1-integrins and RhoGTPases play significant roles in facilitating efficient Yop injection into host cells . The translocation process is highly regulated and essential for YopE to exert its effects on host cells.

What cellular changes does YopE induce in host cells?

When translocated into host cells, YopE induces several observable changes:

  • Increased electrophoretic mobility of the small GTPase RhoA

  • Acidic shift of RhoA as determined by isoelectric focusing

  • Redistribution of membrane-bound RhoA toward the cytosol

  • Specific disruption of RhoA-controlled actin stress fibers

  • Prevention of phagocytosis through cytoskeletal disruption

These changes collectively contribute to Y. enterocolitica's ability to evade host immune responses and establish infection . The cytoskeletal disruption is particularly important as it prevents immune cells from engulfing and clearing the bacteria.

How does the host ubiquitin-proteasome system regulate YopE activity?

Research has revealed a sophisticated interplay between YopE and the host ubiquitin-proteasome system that significantly impacts bacterial virulence. YopE of Y. enterocolitica serogroup O8 is degraded in host cells through polyubiquitination and subsequent proteasomal degradation .

When researchers mutagenized the lysine polyubiquitin acceptor sites of YopE in the Y. enterocolitica serogroup O8 virulence plasmid, the resulting mutant strain:

  • Escaped polyubiquitination and degradation of YopE

  • Displayed increased intracellular YopE levels

  • Showed a pronounced cytotoxic effect on infected cells in vitro

  • Paradoxically demonstrated reduced dissemination into liver and spleen following enteral infection of mice

  • Exhibited diminished delivery of YopP and YopH into host cells

These findings suggest that Y. enterocolitica exploits the host ubiquitin-proteasome system to destabilize YopE, maintaining optimal levels for effective virulence protein delivery. This represents a sophisticated mechanism by which the bacterium fine-tunes its virulence arsenal .

YopE StatusIn vitro EffectIn vivo EffectImpact on Other Yops
Wild-type YopENormal cytotoxicityNormal disseminationNormal delivery
Stabilized YopE (ubiquitin site mutants)Enhanced cytotoxicityReduced disseminationDiminished delivery of YopP and YopH
YopE deletionIncreased cytotoxicity (possibly due to other Yops)Impaired survival in GI tract and lymph tissuesUnknown

What is the molecular relationship between YopE and RhoGTPases?

YopE functionally interacts with RhoGTPases, particularly RhoA, in host cells through the following mechanisms:

  • YopE induces an increase in the electrophoretic mobility of RhoA

  • YopE-dependent modification results in an acidic shift of RhoA (demonstrated by isoelectric focusing)

  • This modification leads to redistribution of membrane-bound RhoA toward the cytosol

  • YopE specifically disrupts RhoA-controlled actin stress fibers

  • The interaction effectively inactivates RhoA function, preventing its normal role in cytoskeletal organization

This targeted disruption of RhoA signaling is central to YopE's ability to prevent phagocytosis and contribute to bacterial survival in the host . The specificity of this interaction highlights the evolved precision of bacterial virulence mechanisms.

What methodological approaches are most effective for studying YopE translocation?

Several experimental approaches have proven particularly valuable for investigating YopE translocation and function:

  • Reporter Systems:

    • YopE-beta-lactamase hybrid proteins combined with fluorescent substrates sensitive to beta-lactamase cleavage

    • Allows tracking of Yop injection in both cell culture and mouse infection models

    • Has revealed differential targeting of immune cell populations in vivo

  • Genetic Manipulation:

    • Creation of non-polar knockout mutants

    • Site-directed mutagenesis of key residues (e.g., ubiquitin acceptor sites)

    • Complementation studies with wild-type and mutant YopE variants

  • Biochemical Analysis:

    • Electrophoretic mobility assays to detect YopE-induced modifications of RhoA

    • Isoelectric focusing to characterize acidic shifts in target proteins

    • Immunoprecipitation to identify YopE-interacting partners

  • Microscopy Techniques:

    • Fluorescence microscopy to visualize cytoskeletal changes

    • Immunofluorescent staining to track bacterial localization and host cell targeting

    • TUNEL assays to detect apoptotic responses (though this is more relevant to YopP/YopJ)

These complementary approaches provide a comprehensive toolkit for dissecting the complex mechanisms of YopE action during infection.

How does YopE contribute to the regulation of Yop translocation?

YopE plays a significant role in regulating the translocation of other Yop proteins, functioning as part of a feedback mechanism that fine-tunes virulence protein delivery. Research has demonstrated that:

  • Accumulation of degradation-resistant YopE (in ubiquitin site mutants) is accompanied by diminished delivery of YopP and YopH into host cells

  • This suggests YopE levels must be precisely controlled to ensure optimal translocation of the entire Yop virulence arsenal

  • The host ubiquitin-proteasome system is exploited by Y. enterocolitica to maintain intermediate YopE levels that facilitate efficient Yop injection

This regulatory function adds another dimension to YopE's role in Y. enterocolitica pathogenesis, illustrating how the bacterium has evolved sophisticated mechanisms to optimize its virulence strategy during infection .

How do different Yop proteins functionally interact during infection?

Y. enterocolitica employs multiple Yop proteins that work in concert to manipulate host defenses:

Yop ProteinPrimary FunctionCellular TargetsInteraction with Other Yops
YopEDisrupts actin cytoskeletonRhoGTPases (RhoA)Regulates translocation of other Yops
YopHTyrosine phosphataseFocal adhesions, integrin signalingWorks with YopE to prevent phagocytosis
YopP/YopJInduces macrophage apoptosisIntracellular signaling pathwaysRequires functional secretion and translocation mechanisms
YopTCytotoxin, disrupts cytoskeletonRhoA (different mechanism than YopE)Complementary to YopE in cytoskeletal disruption
YopMUnknown precise functionMultiple host proteinsPart of the virulence arsenal

While each Yop has distinct functions, there is functional redundancy, particularly in their antiphagocytic activities. YopH, YopE, YopO, and YopT all contribute to preventing phagocytosis, though deletion of any single one does not eliminate this activity completely . This redundancy ensures robust protection against host defenses while allowing for multifaceted manipulation of host cell functions.

What in vivo models are most suitable for studying YopE functions?

Several experimental models have proven valuable for studying YopE functions in vivo:

  • Mouse Enteral Infection Model:

    • Allows study of natural infection route

    • Enables assessment of bacterial dissemination to lymphoid tissues, liver, and spleen

    • Has revealed that stabilized YopE mutants show reduced spread despite enhanced in vitro cytotoxicity

  • Reporter System Mouse Models:

    • Employing YopE-beta-lactamase hybrid proteins

    • Enables tracking of Yop injection into specific immune cell populations

    • Has demonstrated differential targeting with Yop injection detected in various immune cell types:

      • 13% of F4/80+ cells (macrophages)

      • 11% of CD11c+ cells (dendritic cells)

      • 7% of CD49b+ cells (NK cells)

      • 5% of Gr1+ cells (granulocytes)

      • 2.3% of CD19+ cells (B cells)

      • 2.6% of CD3+ cells (T cells)

  • Cell Culture Models:

    • Macrophage cell lines (e.g., J774A.1)

    • Epithelial cells (HeLa)

    • GD25 and GD25-beta1A cells for studying integrin involvement

These diverse experimental approaches offer complementary perspectives on YopE functions across different biological contexts and can be selected based on specific research questions.

How can researchers distinguish between the effects of YopE and other Yop proteins?

Distinguishing between the effects of different Yop proteins requires careful experimental design:

  • Genetic Approaches:

    • Create single and multiple Yop deletion mutants

    • Use complementation with individual Yop proteins to restore specific functions

    • Employ site-directed mutagenesis to alter functional domains while maintaining protein expression

  • Biochemical and Cellular Assays:

    • YopE specifically affects RhoA and actin stress fibers

    • YopH targets tyrosine-phosphorylated proteins at focal adhesions

    • YopP/YopJ induces apoptosis detectable by TUNEL assays

    • YopT also affects RhoA but through a different mechanism than YopE

  • Recommended Protocol for Distinguishing YopE Effects:

    • Create a panel of Y. enterocolitica strains: wild-type, ΔyopE, ΔyopH, ΔyopP, etc.

    • Infect target cells (e.g., J774A.1 macrophages or HeLa cells)

    • Assess specific cellular changes:

      • Actin cytoskeleton disruption (phalloidin staining)

      • RhoA modification (electrophoretic mobility)

      • Apoptosis markers (for YopP effects)

      • Tyrosine phosphorylation status (for YopH effects)

    • Complement single mutants with plasmid-encoded Yop proteins to confirm specificity

This comprehensive approach allows researchers to attribute observed phenotypes to specific Yop proteins with confidence .

What are the remaining knowledge gaps in YopE research?

Despite significant advances in understanding YopE function, several important questions remain:

  • Structural Details:

    • Complete three-dimensional structure of YopE in complex with its targets

    • Specific binding interfaces with RhoGTPases

    • Conformational changes during host cell interaction

  • Regulatory Mechanisms:

    • Complete characterization of how YopE regulates other Yop translocation

    • Identification of all host factors involved in YopE degradation

    • Temporal dynamics of YopE activity during infection

  • Host Range Variation:

    • Differences in YopE activity across various host species and cell types

    • Potential host-specific adaptations of YopE function

    • Comparative analysis across different Yersinia strains and species

  • Therapeutic Potential:

    • Development of specific inhibitors targeting YopE-RhoGTPase interactions

    • Strategies to manipulate YopE stability for attenuating virulence

    • Exploration of YopE as a potential vaccine component

Addressing these knowledge gaps will require innovative approaches combining structural biology, advanced imaging, systems biology, and in vivo infection models.

How might contradictory data on YopE function be reconciled?

Researchers may encounter seemingly contradictory data regarding YopE function, which can be reconciled through careful consideration of:

  • Strain Differences:

    • Y. enterocolitica has multiple serogroups (e.g., O:8, O:9) with potential variations in YopE function

    • Laboratory strains may differ from clinical isolates

    • YopE function may vary between Yersinia species (Y. enterocolitica vs. Y. pseudotuberculosis vs. Y. pestis)

  • Experimental System Variations:

    • In vitro vs. in vivo settings (e.g., stabilized YopE enhances cytotoxicity in vitro but reduces virulence in vivo)

    • Different cell types respond differently to YopE (macrophages vs. epithelial cells)

    • Variations in infection conditions (MOI, temperature, growth phase)

  • Contextual Effects:

    • YopE functions as part of a complex virulence system

    • Deletion of one Yop may alter the translocation or function of others

    • Host factors vary between experimental systems

When encountering contradictory results, researchers should carefully document all experimental parameters and consider how differences in bacterial strains, host cells, and experimental conditions might explain the discrepancies.

What emerging technologies might advance YopE research?

Several cutting-edge technologies hold promise for advancing YopE research:

  • Advanced Imaging Techniques:

    • Super-resolution microscopy for visualizing YopE-host interactions at nanoscale

    • Live-cell imaging to track YopE dynamics in real-time

    • Correlative light and electron microscopy to link functional and structural observations

  • CRISPR-Cas9 Technology:

    • Precise genome editing of both bacterial and host genes

    • Creation of reporter cell lines to monitor RhoGTPase activity

    • High-throughput screening for host factors involved in YopE function

  • Single-Cell Analysis:

    • RNA-seq to characterize transcriptional responses to YopE at single-cell resolution

    • Mass cytometry to identify differential effects across immune cell populations

    • Microfluidics for studying host-pathogen interactions with precise control

  • Structural Biology Approaches:

    • Cryo-electron microscopy for visualizing YopE-target complexes

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • NMR studies of dynamic protein interactions

These technologies, particularly when used in combination, promise to provide unprecedented insights into the molecular mechanisms of YopE function and its role in Y. enterocolitica pathogenesis.

Product Science Overview

Introduction

Yersinia enterocolitica is a pathogenic bacterium responsible for causing yersiniosis, a zoonotic disease that affects both humans and animals. This bacterium is known for its diverse serotypes and biotypes, with O:9 being one of the significant serotypes. A key virulence factor of pathogenic Yersinia enterocolitica strains is the Yersinia outer protein E (YopE), which plays a crucial role in the bacterium’s ability to infect and survive within the host.

Yersinia Outer Protein E (YopE)

YopE is a part of the type III secretion system (T3SS), a sophisticated mechanism used by Yersinia enterocolitica to inject virulence proteins directly into the host cells. This system is encoded by a plasmid and is essential for the bacterium’s pathogenicity. YopE functions as a GTPase-activating protein (GAP), which targets and inactivates small Rho GTPases in the host cell. This action leads to the inhibition of actin polymerization, disrupting the host cell’s cytoskeleton and aiding in the bacterium’s evasion of the host’s immune response .

Recombinant YopE

Recombinant YopE is produced using Escherichia coli (E. coli) as a host for expression. The recombinant protein is typically non-glycosylated and has a calculated molecular mass of approximately 24 kDa. It is often expressed with a His-tag at the N-terminus to facilitate purification through chromatographic techniques .

The recombinant YopE protein is supplied in a buffer solution containing HEPES, NaCl, and glycerol to ensure stability. It is crucial to store the protein at low temperatures, typically at -20°C or below, to maintain its integrity and avoid multiple freeze-thaw cycles .

Applications and Importance

Recombinant YopE is primarily used for laboratory research purposes. It is instrumental in studying the molecular mechanisms of Yersinia enterocolitica’s pathogenicity and the host-pathogen interactions. By understanding how YopE manipulates the host cell’s cytoskeleton, researchers can develop targeted therapies and preventive measures against yersiniosis.

Additionally, recombinant YopE can be used in immunological studies to investigate the immune response elicited by this virulence factor. It binds to IgG- and IgM-type human antibodies, making it a valuable tool for developing diagnostic assays and vaccines .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.